Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements.
about
The organisation of the stress response, and its relevance to chiropractors: a commentaryDifferential cytokine regulation by NF-kappaB and AP-1 in Jurkat T-cells.Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection.Negative transcriptional regulation of human interleukin 2 (IL-2) gene by glucocorticoids through interference with nuclear transcription factors AP-1 and NF-AT.Immune reconstitution following allogeneic peripheral blood progenitor cell transplantation.Presentation at the National Asthma Campaign International Congress, June 1999. Controlling the inflammatory response through transcriptional mechanisms.Transcription factor-mediated molecular mechanisms involved in the functional cross-talk between cytokines and glucocorticoids.Transcriptional and post-transcriptional mechanisms of glucocorticoid antiproliferative effects.Steroid-free immunosuppression in kidney transplantation: an editorial review.Immune profiling and cancer post transplantationThe immune suppressive effect of dexamethasone in rheumatoid arthritis is accompanied by upregulation of interleukin 10 and by differential changes in interferon gamma and interleukin 4 production.Glucocorticoid therapy of antigen-induced arthritis depends on the dimerized glucocorticoid receptor in T cellsLoss of resistance to murine hepatitis virus strain 3 infection after treatment with corticosteroids is associated with induction of macrophage procoagulant activity.The molecular basis for the effectiveness, toxicity, and resistance to glucocorticoids: focus on the treatment of rheumatoid arthritis.Glucocorticoids in T cell apoptosis and function.Positive and negative regulation of the composite octamer motif of the interleukin 2 enhancer by AP-1, Oct-2, and retinoic acid receptor.Molecular regulation of human interleukin 2 and T-cell function by interleukin 4Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptorDexamethasone augments CXCR4-mediated signaling in resting human T cells via the activation of the Src kinase LckA dynamic assembly of diverse transcription factors integrates activation and cell-type information for interleukin 2 gene regulation.Th2 cells as targets for therapeutic intervention in allergic bronchial asthma.Molecular and functional evidence for in vitro cytokine enhancement of human and murine target cell sensitivity to glucocorticoids. TNF-alpha priming increases glucocorticoid inhibition of TNF-alpha-induced cytotoxicity/apoptosis.Immunosuppressive drug therapy.Development of novel treatment strategies for inflammatory diseases-similarities and divergence between glucocorticoids and GILZ.Glucocorticoids downregulate Fyn and inhibit IP(3)-mediated calcium signaling to promote autophagy in T lymphocytes.Multiple closely-linked NFAT/octamer and HMG I(Y) binding sites are part of the interleukin-4 promoter.Bionutrition and oral cancer in humans.IL-2 gene expression and NF-kappa B activation through CD28 requires reactive oxygen production by 5-lipoxygenaseNegative regulation of transcription in eukaryotes.RelA/p65 is a molecular target for the immunosuppressive action of protein kinase AA novel immunosuppressive factor in bovine colostrum blocks activation of the interleukin 2 gene enhancer at the NFAT site.Interleukin 2 transcription factors as molecular targets of cAMP inhibition: delayed inhibition kinetics and combinatorial transcription roles.Glucocorticoid-mediated repression of intercellular adhesion molecule-1 expression in human monocytic and bronchial epithelial cell lines.Glucocorticoid-mediated inhibition of Lck modulates the pattern of T cell receptor-induced calcium signals by down-regulating inositol 1,4,5-trisphosphate receptors.Glucocorticoid-mediated control of the activation and clonal deletion of peripheral T cells in vivo.Hypothalamic-pituitary-adrenal axis function and cytokine production in multiple sclerosis with or without interferon-beta treatment.Novel insights into the neuroendocrine control of inflammation: the role of GR and PARP1.Increased sensitivity to glucocorticoids in peripheral blood mononuclear cells of chronic fatigue syndrome patients, without evidence for altered density or affinity of glucocorticoid receptors.The effect of methotrexate and glucocorticosteroids on apoptosis of phythemaglutinin-stimulated mononuclear cells from peripheral blood.Altered neuroimmunoendocrine communication during a condition of chronically increased brain corticotropin-releasing hormone drive.
P2860
Q27498871-AD059756-6FDE-4CEE-B38E-2EE1F80DCF0FQ33589330-F0D9BD84-A607-41C0-865F-5E4CB69994EBQ33779655-CEDFBE56-16C1-4CC3-8BA2-2CEFA60595C0Q33895733-9DFA12B0-C4CE-4D84-8E89-0B1BA6CBBA5AQ34066661-99C61D9A-3385-40FC-A419-E29DB9A93427Q34106909-CD14D28E-4F48-4A76-AA90-7C8BAFB6BEBBQ34328150-96496D21-E9F2-4C21-98E5-680006A38174Q34580606-6AE312F3-93F2-4EC1-BFA2-1CD044B09585Q34719096-8B0CA803-DD71-4F4B-8E93-D8E4867CAB1AQ35050810-F1AC8029-EC52-4D8D-8345-A3E44DC45779Q35548182-13BB7822-94F3-4FE4-91C3-6AA20C41F516Q35585748-10A09159-E49E-4141-AC30-78DD4237F016Q35863381-FDA14F53-16B7-449D-896A-872DABD6043EQ36132386-3A8C233A-21F8-4628-AF3F-C58E1C320AABQ36325611-8DFAC194-7919-4453-BAAB-6F43C795E821Q36363848-31006407-E9A7-427F-8B27-446771540E2BQ36487389-8DD24188-ED26-4AE6-82A0-50EA0B6481A1Q36555534-0CE07481-BB1B-4C57-869D-BFC54E7BB63FQ37066236-61909639-FF0C-4EA2-BBAA-905503C8D7C7Q37349310-465B09FC-C83A-4853-99AD-3C5A36282AE5Q37355888-D3C9AA7E-B63C-4AD3-8AE0-5FAFEC4AD58DQ37359871-A468A60D-7006-4718-B08A-8600808504DEQ38134066-16D5DD7A-A293-4C3A-83B4-677757ED1C56Q38237635-66969AF9-16F6-4F48-BCB9-9F96618B8600Q39660061-23E61F16-5702-44DE-A612-8F40B48FFBA5Q40412449-1B67C32A-3F15-43DC-850A-4707557CB1D2Q40458905-6D1FBED2-DF21-4046-9083-82AD2EFA0A9FQ40788999-161669FE-3D96-4766-8A2A-2874BEE221FCQ40800435-FED97A01-AAB8-43CF-9B9F-0AD20793E764Q40806596-A1C6328E-6427-446D-AC23-C1DF5CB0E229Q41244395-CAB631D0-69BE-4F87-85A5-B77A535C14CBQ41483826-6C20839F-C132-4F11-AC30-E3970DA720AFQ41571869-FCAD294C-AA77-4983-9E91-E4AE983D7F35Q41851289-BE1D1B2A-4EF3-4AA2-8C82-A0A582BB7E4CQ42126206-786D9361-5E41-444C-B077-B19D6596C07BQ42520744-E4A0946F-623F-45DA-8FA2-5AD157699A3BQ42781123-44D4C93B-94D5-4793-92E5-CA4DE5022A41Q43565888-1A07E77C-5B4F-409D-8F57-B3CB0DF20A1BQ45231373-99BFE1F6-CF22-4E4A-AE03-38E1229FA895Q47966577-53CB77A2-C49B-4EA7-9AB6-C7C683BD2D8C
P2860
Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Glucocorticoid receptor-mediat ...... ls and AP-1 enhancer elements.
@ast
Glucocorticoid receptor-mediat ...... ls and AP-1 enhancer elements.
@en
type
label
Glucocorticoid receptor-mediat ...... ls and AP-1 enhancer elements.
@ast
Glucocorticoid receptor-mediat ...... ls and AP-1 enhancer elements.
@en
prefLabel
Glucocorticoid receptor-mediat ...... ls and AP-1 enhancer elements.
@ast
Glucocorticoid receptor-mediat ...... ls and AP-1 enhancer elements.
@en
P2093
P2860
P356
P1476
Glucocorticoid receptor-mediat ...... ls and AP-1 enhancer elements.
@en
P2093
Martinotti S
Petrangeli E
Screpanti I
P2860
P304
P356
10.1084/JEM.175.3.637
P407
P577
1992-03-01T00:00:00Z